BGV Partner Daniela Couto will participate in the Johnson & Johnson Innovation webinar “Investor Perspective: How Can Partnering with Pharma Impact Startup Success?” A panel of investors will share their views on collaborating and partnering with pharma companies.
The session will focus on the European biotech ecosystem and will include insight from BGV’s Daniela Couto who together with Gina Melcher von Dydiowa and Sander van Deventer of Forbion jointly published the results of an investigation of pharma involvement in biotech startup success in a March issue of Nature Biotechnology. The article indicated that formal ties to pharma strongly correlate with biotech startup success at the clinical as well as preclinical stage. Based on their analysis, the authors emphasized the need for continuous involvement with pharma throughout the life cycle of startups.
Participants can register here.